Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Urinary Bladder Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Myeloproliferative Disorders 1Multiple Myeloma 1Mesothelioma, Malignant 1Melanoma 1Carcinoma, Squamous Cell 1

Interventions

Pemetrexed 4Cisplatin 4pembrolizumab 3Nivolumab 3Interleukin-2 3Carboplatin 3atezolizumab 2aldesleukin 2Pharmaceutical Preparations 2Ipilimumab 2olaparib 1lenvatinib 1fludarabine 1enzalutamide 1Thoracoscopy 1Thoracic Surgery, Video-Assisted 1Surgery, Computer-Assisted 1Proton Therapy 1Platinum 1Paclitaxel 1Injections 1Influenza Vaccines 1Indocyanine Green 1In Situ Hybridization, Fluorescence 1Cyclophosphamide 1Combined Modality Therapy 1Cerebral Decortication 1Brentuximab Vedotin 1Blood Component Removal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Mesothelioma, Malignant × In Situ Hybridization, Fluorescence × Clear all
NCT07403630 2026-02-17

IT-TCP POS

Azienda Ospedaliero-Universitaria di Parma

Phase NA Recruiting
300 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmOther solid neoplasmPlasma cellThoracic

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Carcinoma, Squamous Cell, Melanoma, Multiple Myeloma, Myeloproliferative Disorders, Ovarian Neoplasms, Pancreatic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡